Kenneth E. Sherman mainly focuses on Internal medicine, Immunology, Hepatitis C virus, Gastroenterology and Hepatitis C. His Internal medicine study combines topics in areas such as Ribavirin, Telaprevir and Sofosbuvir. His research investigates the connection between Immunology and topics such as Liver disease that intersect with issues in Cirrhosis.
Kenneth E. Sherman combines subjects such as Coinfection and Genotype with his study of Hepatitis C virus. The concepts of his Gastroenterology study are interwoven with issues in Clinical trial, Randomized controlled trial, Surgery, Chemotherapy and Liver biopsy. His Hepatitis C research incorporates themes from Adverse effect, Viral load, Interferon alfa, Hazard ratio and Concomitant.
Internal medicine, Virology, Hepatitis C virus, Immunology and Hepatitis C are his primary areas of study. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Ribavirin, Telaprevir. His Gastroenterology research integrates issues from Fibrosis and Liver biopsy.
The study of Virology is intertwined with the study of Genotype in a number of ways. His Hepatitis C virus research incorporates elements of Coinfection, Protease inhibitor and Transplantation. His Immunology research is multidisciplinary, relying on both Liver disease and Acquired immunodeficiency syndrome.
The scientist’s investigation covers issues in Internal medicine, Hepatitis C virus, Virology, Cohort and Hepatitis C. He frequently studies issues relating to Gastroenterology and Internal medicine. His Gastroenterology course of study focuses on Cause of death and Liver related mortality.
The various areas that Kenneth E. Sherman examines in his Hepatitis C virus study include Coinfection, Kidney, Transplantation and Hepatitis B virus. His Hepatitis C research includes elements of Pibrentasvir, Ribavirin, Glecaprevir, Regimen and Hepacivirus. Kenneth E. Sherman interconnects Liver transplantation, Immunology, Hepatitis and Hiv hcv coinfection in the investigation of issues within Liver disease.
Kenneth E. Sherman mainly investigates Internal medicine, Hepatitis C, Hepatitis C virus, Glecaprevir and Pibrentasvir. His Internal medicine research is multidisciplinary, incorporating perspectives in Lipodystrophy and Drug. His Hepatitis C research entails a greater understanding of Immunology.
His work deals with themes such as Chemotherapy and Genotype, Hepatitis E virus, which intersect with Immunology. His Hepatitis C virus research includes themes of Gastroenterology, Genomic data, National Death Index and Coinfection. His Hepatic fibrosis study, which is part of a larger body of work in Gastroenterology, is frequently linked to Blockade, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins.
The New England Journal of Medicine (2004)
Response-guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Kenneth K.E. Sherman;Steven S.L. Flamm;Nezam N.H. Afdhal;David Nelson.
The New England Journal of Medicine (2011)
Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group
Kenneth E. Sherman;Susan D. Rouster;Raymond T. Chung;Natasa Rajicic.
Clinical Infectious Diseases (2002)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston.
Annals of Internal Medicine (2002)
Hepatitis C virus infection in USA: an estimate of true prevalence
Eric W Chak;Andrew H. Talal;Kenneth E. Sherman;Eugene R. Schiff.
Liver International (2011)
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
David L. Wyles;Peter J. Ruane;Mark S. Sulkowski;Douglas Dieterich.
The New England Journal of Medicine (2015)
Fronts in Large Marine Ecosystems
Igor M. Belkin;Peter C. Cornillon;Kenneth Sherman.
Progress in Oceanography (2009)
Principles for the conservation of wild living resources
Marc Mangel;Lee M. Talbot;Gary K. Meffe;M. Tundi Agardy.
(1996)
Large Marine Ecosystems: Stress, Mitigation and Sustainability
Kenneth Sherman;Lewis M. Alexander;Barry D. Gold.
(1995)
Mechanism of indinavir-induced hyperbilirubinemia
Stephen D. Zucker;Xiaofa Qin;Susan D. Rouster;Fei Yu.
Proceedings of the National Academy of Sciences of the United States of America (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Hamad Medical Corporation
Harvard University
University of California, San Francisco
Johns Hopkins University School of Medicine
Harvard Medical School
Inova Fairfax Hospital
University of Tennessee Health Science Center
New York University
University College London
University of North Carolina at Chapel Hill
University of Chicago
Stanford University
University of Naples Federico II
University of Strasbourg
Leipzig University
Tsinghua University
University of Groningen
Centre national de la recherche scientifique, CNRS
Los Alamos National Laboratory
University of Idaho
Cornell University
York University
Manhattan Eye, Ear and Throat Hospital
The University of Texas MD Anderson Cancer Center
Appalachian State University
University of Sheffield